These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33820673)

  • 1. Role of newer antidiabetic drugs on cardiovascular prevention and heart failure.
    Rojas-Velázquez JM; Giralt-Herrera A; Leiva-Enríquez J; Leiva-Enríquez J
    Clin Investig Arterioscler; 2021; 33(6):314-322. PubMed ID: 33820673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type 2 diabetes mellitus: new treatments].
    Ascaso JF
    Med Clin (Barc); 2014 Aug; 143(3):117-23. PubMed ID: 23937815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study.
    Ena J; Carretero-Gómez J; Zapatero-Gaviria A; Carrasco-Sánchez FJ; Del Romero-Sánchez M; González-Becerra C; Blazquez-Encinar JC; Iguzquiza-Pellejero MJ; de Escalante Yangüela B; Gómez-Huelgas R;
    Rev Clin Esp (Barc); 2021 Nov; 221(9):517-528. PubMed ID: 34752263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New glucose-lowering drugs for reducing cardiovascular risk in patients with type2 diabetes mellitus].
    Gorgojo-Martínez JJ
    Hipertens Riesgo Vasc; 2019; 36(3):145-161. PubMed ID: 31079957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes.
    Gorgojo Martínez JJ
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():8-16. PubMed ID: 28760227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile of patients with type 2 diabetes mellitus treated with sodium- glucose cotransporter-2 inhibitors and experience in real-world clinical practice in Spain.
    Cuatrecasas G; Goñi-Goicoechea F
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():30-34. PubMed ID: 28760223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
    Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
    Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight and type 2 diabetes: new recommendations.
    Gómez Huelgas R
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():17-21. PubMed ID: 28760220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials.
    Giugliano D; Maiorino MI; Longo M; Bellastella G; Chiodini P; Esposito K
    Endocrine; 2019 Jul; 65(1):15-24. PubMed ID: 31028667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and cardiovascular prevention: the dogmas disputed.
    Giugliano D; Maiorino MI; Bellastella G; Esposito K
    Endocrine; 2018 May; 60(2):224-228. PubMed ID: 28895030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study.
    Ena J; Carretero-Gómez J; Zapatero-Gaviria A; Carrasco Sánchez FJ; Del Romero-Sánchez M; González-Becerra C; Blazquez-Encinar JC; Iguzquiza-Pellejero MJ; de Escalante Yangüela B; Gómez-Huelgas R; ;
    Rev Clin Esp; 2020 Apr; ():. PubMed ID: 32279949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of anti-diabetic therapy based on glucagon-like peptide-1 receptor agonists on the cardiovascular risk of patients with type 2 diabetes mellitus].
    Camafort-Babkowski M
    Med Clin (Barc); 2013 Aug; 141(4):167-74. PubMed ID: 23332622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network meta-analysis of nine large cardiovascular outcome trials of new antidiabetic drugs.
    Alfayez OM; Al Yami MS; Alshibani M; Fallatah SB; Al Khushaym NM; Alsheikh R; Alkhatib N
    Prim Care Diabetes; 2019 Jun; 13(3):204-211. PubMed ID: 30713085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approach to diabetes care: from blood glucose to cardiovascular disease.
    Aguiar C; Duarte R; Carvalho D
    Rev Port Cardiol (Engl Ed); 2019 Jan; 38(1):53-63. PubMed ID: 30685291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular safety outcomes of new antidiabetic therapies.
    LeBras MH; Barry AR; Koshman SL
    Am J Health Syst Pharm; 2017 Jul; 74(13):970-976. PubMed ID: 28483748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.
    Patoulias D; Boulmpou A; Imprialos K; Stavropoulos K; Papadopoulos C; Doumas M
    Rev Clin Esp (Barc); 2022 Apr; 222(4):229-232. PubMed ID: 34167924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on cardiovascular effects of newer hypoglycaemic medications.
    Cutshall BT; Twilla JD; Olinger AS; Oliphant CS
    Ann Med; 2017 Nov; 49(7):603-612. PubMed ID: 28540743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antidiabetic drugs and cardiovascular risk: Primum non nocere.
    Bonadonna RC; Borghi C; Consoli A; Volpe M
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):759-66. PubMed ID: 27373139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of clinical trials on the cardiovascular effects of hypoglycemic drugs in people with type 2 diabetes.
    Romero A; Llauradó G; González-Clemente JM
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Dec; 68(10):741-750. PubMed ID: 34924163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefits.
    Hupfeld C; Mudaliar S
    Diabetes Obes Metab; 2019 Aug; 21(8):1780-1789. PubMed ID: 30957945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.